CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-14 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +20,835 | 231,071 | ||
| 2025-01-14 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −9,955 | $5.89 | $59K | 221,116 |
| 2025-01-14 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −20,835 | 0 | ||
| 2025-01-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +2,813 | 65,464 | ||
| 2025-01-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,578 | $5.89 | $9K | 63,886 |
| 2025-01-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −2,813 | 0 | ||
| 2025-01-14 | BILINSKY IGOR Chief Operating Officer | Option exercise | +2,813 | 60,352 | ||
| 2025-01-14 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,578 | $5.89 | $9K | 58,774 |
| 2025-01-14 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −2,813 | 0 | ||
| 2024-12-16 | Puri Raj K. Chief Regulatory Officer | Option exercise | +8,334 | 159,171 | ||
| 2024-12-16 | Puri Raj K. Chief Regulatory Officer | Shares withheld for taxes | −3,759 | $7.84 | $29K | 155,412 |
| 2024-12-16 | Puri Raj K. Chief Regulatory Officer | Option exercise · Restricted Stock Units | −8,334 | 8,334 | ||
| 2024-12-02 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +10,417 | 214,662 | ||
| 2024-12-02 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −4,426 | $9.07 | $40K | 210,236 |
| 2024-12-02 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −10,417 | 52,087 | ||
| 2024-12-02 | BILINSKY IGOR Chief Operating Officer | Option exercise | +3,516 | 59,323 | ||
| 2024-12-02 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,784 | $9.07 | $16K | 57,539 |
| 2024-12-02 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −3,516 | 17,581 | ||
| 2024-12-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +3,906 | 64,633 | ||
| 2024-12-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,982 | $9.07 | $18K | 62,651 |
Page 11 of 14 · 280 trades